Financing, Equity Capital Markets
CymaBay Therapeutics, Inc.
09/23
|
$258.7 Million
做厙勛圖 served as bookrunner for CymaBay Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sector
Sub-Sector
Biopharma